Adagio Medical Holdings (ADGM) Total Non-Current Liabilities (2023 - 2026)
Adagio Medical Holdings (ADGM) posted Total Non-Current Liabilities of $33.3 million for Q1 2026, up 8.47% sequentially from $30.7 million in Q4 2025, and up 31.58% YoY from $25.3 million in Q1 2025.
Adagio Medical Holdings (ADGM) Total Non-Current Liabilities (2023 - 2026) Analysis & Trends
Adagio Medical Holdings has reported Total Non-Current Liabilities for 4 years, with the latest figure at $33.3 million in Q1 2026.
- Quarterly Total Non-Current Liabilities rose 31.58% year-over-year to $33.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $33.3 million (up 31.58% YoY) and the FY2025 annual result came in at $30.7 million, up 23.27% from the prior year.
- Total Non-Current Liabilities rose to $33.3 million in Q1 2026 per ADGM's latest filing, from $30.7 million in the prior quarter.
- Over five years, Total Non-Current Liabilities peaked at $47.4 million in Q4 2023 and troughed at $24.9 million in Q4 2024.
- A 4-year average of $31.1 million and a median of $29.4 million in 2024 frame the typical range for Total Non-Current Liabilities.
- The sharpest annual moves came in 2024 and 2026: Total Non-Current Liabilities plunged 47.39% in 2024, then jumped 31.58% in 2026.
- Over 4 years, Total Non-Current Liabilities stood at $47.4 million in 2023, then slumped by 47.39% to $24.9 million in 2024, then rose by 23.27% to $30.7 million in 2025, then increased by 8.47% to $33.3 million in 2026.
- According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $33.3 million, $30.7 million, and $32.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 21.28 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 40.90 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 42.74 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 2.57 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 3.68 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 23.89 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 9.07 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 3.44 Bn |
| 10 | Adagio Medical Holdings | 14.11 Mn | 14.11 Mn | - | 34.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 34.22 Mn |
| Mar 31, 2026 | 33.32 Mn |
| Dec 31, 2025 | 30.72 Mn |
| Sep 30, 2025 | 32.37 Mn |
| Jun 30, 2025 | 26.96 Mn |
| Mar 31, 2025 | 25.32 Mn |
| Dec 31, 2024 | 24.92 Mn |
| Sep 30, 2024 | 28.17 Mn |
| Dec 31, 2023 | 47.37 Mn |